Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China flag China · Delayed Price · Currency is CNY
30.95
-2.50 (-7.47%)
Aug 21, 2026, 1:45 PM CST

SHE:301130 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
44.0129.51190.68334.37202.78148.63
Short-Term Investments
--0.052.760.141.57
Trading Asset Securities
178.03206.9584.93213.15413.1765
Cash & Short-Term Investments
222.05236.46275.65550.28616.08215.2
Cash Growth
-15.79%-14.22%-49.91%-10.68%186.28%22.20%
Accounts Receivable
51.5755.7357.4349.1456.7858.44
Other Receivables
3.532.353.963.663.233.36
Receivables
55.0958.0861.3952.8160.0161.8
Inventory
31.6928.1927.9727.3620.726.58
Other Current Assets
21.3120.147.893.317.3711.35
Total Current Assets
330.14342.86372.91633.76704.17314.93
Property, Plant & Equipment
531.26538.02507.79371.64267.94240.97
Long-Term Investments
11----
Goodwill
30.5730.5730.57---
Other Intangible Assets
12796.7799.8525.5726.6327.68
Long-Term Deferred Tax Assets
10.4310.027.927.597.857.9
Long-Term Deferred Charges
0.780.86----
Other Long-Term Assets
16.241.4743.5428.6310.423.13
Total Assets
1,0471,0621,0631,0671,017594.61

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
33.9248.8442.4328.456.126.24
Accrued Expenses
2.2619.641714.4620.8821.34
Short-Term Debt
11.6611.5310---
Current Portion of Leases
0.040.080.120.12--
Finance Div. Other Current Liabilities
----1.5-
Current Income Taxes Payable
0.1602.080.48-0.08
Current Unearned Revenue
1.453.032.425.416.33.3
Other Current Liabilities
20.375.35.064.783.943.73
Total Current Liabilities
69.8588.4279.1153.738.7434.69
Long-Term Leases
--0.080.2--
Long-Term Unearned Revenue
32.7233.637.1229.6132.735.78
Long-Term Deferred Tax Liabilities
4.694.785.110.740.28-
Other Long-Term Liabilities
---0.08--
Total Liabilities
135.16126.8121.4184.3371.7170.47

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
76.4976.4980.880.880.860.6
Additional Paid-In Capital
363.57363.57461.37461.37461.3790.64
Retained Earnings
472.14462.95460.94440.69403.11372.9
Treasury Stock
-30.99--100.01---
Comprehensive Income & Other
1.081.252.64---
Total Common Equity
882.3904.27905.75982.86945.29524.14
Minority Interest
29.9330.5135.42---
Shareholders' Equity
912.23934.78941.16982.86945.29524.14
Total Liabilities & Equity
1,0471,0621,0631,0671,017594.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
39.5911.6110.20.32--
Net Cash (Debt)
182.46224.85265.46549.96616.08215.2
Net Cash Growth
-28.06%-15.30%-51.73%-10.73%186.28%22.20%
Net Cash Per Share
2.392.943.416.817.963.55
Filing Date Shares Outstanding
75.4976.4976.4980.880.880.8
Total Common Shares Outstanding
75.4976.4976.4980.880.860.6
Working Capital
260.29254.44293.8580.06665.44280.24
Book Value Per Share
11.6911.8211.8412.1611.708.65
Tangible Book Value
724.73776.93775.33957.29918.66496.46
Tangible Book Value Per Share
9.6010.1610.1411.8511.378.19
Buildings
-510.46396.8306.44276.72265.7
Machinery
-162.11121.2108.6104.63102.37
Construction In Progress
-95.71192.83134.8652.5313.93